SAN FRANCISCO, CA, UNITED STATES, January 13, 2026 /EINPresswire.com/ -- Bringing together public institutions, ...

A surge in Inventiva shares, up about 50% in the first few weeks of 2026, highlights investors' appetite for ​betting on the ...

For biotech companies the past two years have been challenging. Biotech investments have not reached the record levels of ...

Pfizer has spent billions of dollars on acquisitions in the past few decades. Its biggest deals include Warner-Lambert, ...

But deciding if it's a good buy takes a little more looking.

Biotech headwinds are driving double-digit revenue growth and profitability for these two mid-caps.

Delve into what 2026 has to offer in the biotech industry. The market is showing signs it's picking up and the patent cliff ...

Explore how leadership in biotech drives success through a milestone approach, aligning teams and culture from science to ...

China quietly became biotech’s back-office, from molecule synthesis and clinical trials to novel drug licensing. Now the ...

Department of Economic & Community Development Commissioner Daniel O'Keefe speaks at the BioCT legislative breakfast in New ...

DermCeutical EDLTM is a topical bioactive ingredient that Debut claims delivers skin-tightening benefits.

A life sciences hub in Syracuse is getting a major upgrade as New York pushes to grow its biotechnology sector. Gov. Kathy ...